Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free GEHC Stock Alerts

GE HealthCare Technologies (GEHC) Competitors

GE HealthCare Technologies logo
$64.81 +0.68 (+1.06%)
As of 04:00 PM Eastern
Compare

GEHC vs. PHG, SYK, BSX, BDX, and EW

Should you buy GE HealthCare Technologies stock or one of its competitors? GE HealthCare Technologies's main competitors and comparable companies include Koninklijke Philips (PHG), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), and Edwards Lifesciences (EW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does GE HealthCare Technologies compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.4%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has a net margin of 9.33% compared to Koninklijke Philips' net margin of 6.30%. GE HealthCare Technologies' return on equity of 20.12% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips6.30% 14.38% 5.96%
GE HealthCare Technologies 9.33%20.12%5.74%

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$20.17B1.21$1.01B$1.3618.32
GE HealthCare Technologies$20.63B1.42$2.08B$4.3614.86

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Koninklijke Philips has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

GE HealthCare Technologies has a consensus target price of $77.73, indicating a potential upside of 19.93%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

In the previous week, GE HealthCare Technologies had 6 more articles in the media than Koninklijke Philips. MarketBeat recorded 11 mentions for GE HealthCare Technologies and 5 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.64 beat GE HealthCare Technologies' score of 0.46 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
3 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

GE HealthCare Technologies beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Stryker?

GE HealthCare Technologies (NASDAQ:GEHC) and Stryker (NYSE:SYK) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Stryker pays an annual dividend of $3.52 per share and has a dividend yield of 1.3%. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Stryker pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years and Stryker has raised its dividend for 32 consecutive years. Stryker is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Stryker had 3 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 14 mentions for Stryker and 11 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 0.46 beat Stryker's score of 0.23 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
3 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stryker
3 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

GE HealthCare Technologies has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Stryker has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by insiders. Comparatively, 4.6% of Stryker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Stryker has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$20.63B1.42$2.08B$4.3614.86
Stryker$25.12B4.18$3.25B$9.6528.36

Stryker has a net margin of 14.43% compared to GE HealthCare Technologies' net margin of 9.33%. Stryker's return on equity of 23.63% beat GE HealthCare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies9.33% 20.12% 5.74%
Stryker 14.43%23.63%11.39%

GE HealthCare Technologies currently has a consensus target price of $77.73, indicating a potential upside of 19.93%. Stryker has a consensus target price of $378.13, indicating a potential upside of 38.16%. Given Stryker's stronger consensus rating and higher possible upside, analysts plainly believe Stryker is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48
Stryker
0 Sell rating(s)
5 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.78

Summary

Stryker beats GE HealthCare Technologies on 16 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

Boston Scientific has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

Boston Scientific has a net margin of 17.50% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Boston Scientific17.50% 19.28% 10.89%
GE HealthCare Technologies 9.33%20.12%5.74%

Boston Scientific has higher earnings, but lower revenue than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$20.07B3.16$2.90B$2.4717.70
GE HealthCare Technologies$20.63B1.42$2.08B$4.3614.86

In the previous week, Boston Scientific had 1 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 12 mentions for Boston Scientific and 11 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 0.46 beat Boston Scientific's score of 0.39 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boston Scientific
6 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
GE HealthCare Technologies
3 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Boston Scientific currently has a consensus target price of $70.27, indicating a potential upside of 60.76%. GE HealthCare Technologies has a consensus target price of $77.73, indicating a potential upside of 19.93%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific
2 Sell rating(s)
6 Hold rating(s)
23 Buy rating(s)
0 Strong Buy rating(s)
2.68
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of Boston Scientific shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Boston Scientific beats GE HealthCare Technologies on 10 of the 16 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, GE HealthCare Technologies had 2 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 11 mentions for GE HealthCare Technologies and 9 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 1.09 beat GE HealthCare Technologies' score of 0.46 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
5 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
3 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Becton, Dickinson and Company currently has a consensus price target of $187.67, suggesting a potential upside of 3.91%. GE HealthCare Technologies has a consensus price target of $77.73, suggesting a potential upside of 19.93%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.41
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

Becton, Dickinson and Company has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

GE HealthCare Technologies has lower revenue, but higher earnings than Becton, Dickinson and Company. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$21.84B2.28$1.68B$3.3254.40
GE HealthCare Technologies$20.63B1.42$2.08B$4.3614.86

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.3%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Becton, Dickinson and Company has increased its dividend for 53 consecutive years and GE HealthCare Technologies has increased its dividend for 1 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

GE HealthCare Technologies has a net margin of 9.33% compared to Becton, Dickinson and Company's net margin of 4.52%. GE HealthCare Technologies' return on equity of 20.12% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company4.52% 14.79% 6.93%
GE HealthCare Technologies 9.33%20.12%5.74%

Summary

GE HealthCare Technologies beats Becton, Dickinson and Company on 10 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Edwards Lifesciences?

Edwards Lifesciences (NYSE:EW) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

GE HealthCare Technologies has higher revenue and earnings than Edwards Lifesciences. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$6.07B8.37$1.07B$1.7450.70
GE HealthCare Technologies$20.63B1.42$2.08B$4.3614.86

Edwards Lifesciences presently has a consensus target price of $100.27, indicating a potential upside of 13.66%. GE HealthCare Technologies has a consensus target price of $77.73, indicating a potential upside of 19.93%. Given GE HealthCare Technologies' higher possible upside, analysts clearly believe GE HealthCare Technologies is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
0 Sell rating(s)
6 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.74
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

Edwards Lifesciences has a net margin of 15.43% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Edwards Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences15.43% 15.68% 12.05%
GE HealthCare Technologies 9.33%20.12%5.74%

In the previous week, GE HealthCare Technologies had 4 more articles in the media than Edwards Lifesciences. MarketBeat recorded 11 mentions for GE HealthCare Technologies and 7 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.10 beat GE HealthCare Technologies' score of 0.46 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
3 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Edwards Lifesciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Summary

Edwards Lifesciences and GE HealthCare Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get GE HealthCare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEHC vs. The Competition

Export
MetricGE HealthCare TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$28.97B$5.55B$7.26B$12.97B
Dividend Yield0.22%1.80%2.53%12.80%
P/E Ratio14.8625.32274.6925.77
Price / Sales1.4272.08647.7490.25
Price / Cash10.9133.1128.0434.72
Price / Book2.845.8810.566.36
Net Income$2.08B$151.55M$3.49B$358.17M
7 Day Performance0.87%0.18%-0.23%0.54%
1 Month Performance-13.38%-3.93%-2.80%-2.95%
1 Year Performance-13.48%6.57%18.25%6.08%

GE HealthCare Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEHC
GE HealthCare Technologies
4.0301 of 5 stars		$64.81
+1.1%		$77.73
+19.9%		-14.4%$28.97B$20.63B14.8654,000
PHG
Koninklijke Philips
2.9978 of 5 stars		$25.08
+2.0%		N/A-12.3%$24.17B$20.17B18.4865,340
SYK
Stryker
4.9284 of 5 stars		$282.06
+2.4%		$380.40
+34.9%		-27.0%$105.70B$25.12B29.2356,000
BSX
Boston Scientific
4.8733 of 5 stars		$44.85
+4.3%		$71.46
+59.3%		-55.6%$62.29B$20.07B18.1659,000
BDX
Becton, Dickinson and Company
3.5625 of 5 stars		$183.21
+3.0%		$187.67
+2.4%		-3.6%$49.00B$21.84B55.1872,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GEHC) was last updated on 9/21/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel